Close menu



Emicizumab-like - Labelled (Arg,Lys) 13C15N


Quantification of Emicizumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Emicizumab-like is a recombinant, stable isotope labelled monoclonal IgG4-Lambdaantibody containing proteotypic peptide derived from Emicizumab’s originator sequence. Labelled Emicizumab-like is designed for use as an internal standard for quantitative analysis of Emicizumab in plasma samples. Emicizumab targets Factor IXa and Factor X used to treat hemophilia A.

This product is for research use only and is not intended for diagnostic or therapeutic use.